UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.
Researchers have received funding to seek and validate biomarkers for the progressive, inherited disease Friedreich’s ataxia, a life-shortening degenerative neuromuscular disorder.
UAB researchers discover a new protein interaction from the 1918 flu strain that may help influenza circumvent the host immune response that would fight viral infection.
Louise T. Chow, Ph.D., professor in the Department of Biochemistry and Molecular Genetics, has been chosen as one of the Women of Consequence honorees for the 2015 International Women’s Day Awards Dinner.
Professor of Microbiology David Briles, Ph.D., and Professor of Optometry Lawrence DeLucas, O.D., Ph.D., will be inducted into the NIA, professional distinction accorded to academic inventors.
The new 1,600-square-foot Central Alabama High-Field Nuclear Magnetic Resonance Facility provides state-of-the-art sensitivity and resolution for biomedical research and drug discovery.
The University of Alabama System Board of Trustees approved the establishment of the James K. Kirklin, M.D., Endowed Lectureship and other faculty appointments during its Nov. 8 meeting.
Researchers found differences in polymerase chains thought to be similar, potentially opening new pathways toward cancer drug development.
Louise Chow, Ph.D., professor in the Department of Biochemistry and Molecular Genetics and senior scientist at the UAB Comprehensive Cancer Center, was elected a foreign associate of the National Academy of Sciences for excellence in original scientific research.